Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Optical coherence tomography-guided percutaneous coronary intervention in multivessel coronary disease with complex lesions.

Created on 27 Aug 2026

Authors

In Tae Jin, Seung-Jun Lee, Jong-Young Lee, Sang-Min Kim, Seung-Ho Hur, Jung Ho Heo, Ji-Yong Jang, Jin-Sin Koh, Hoyoun Won, Jun-Won Lee, Soon Jun Hong, Dong-Kie Kim, Jeong Cheon Choe, Jin Bae Lee, Tae-Hyun Yang, Jung-Hee Lee, Young Joon Hong, Jong-Hwa Ahn, Sang-Hyup Lee, Yong-Joon Lee, Sung-Jin Hong, Chul-Min Ahn, Jung-Sun Kim, Myeong-Ki Hong, Yangsoo Jang, Jin Won Kim, Byeong-Keuk Kim

Published in

Heart (British Cardiac Society). Aug 26, 2026. Epub Aug 26, 2026.

Abstract

Optical coherence tomography (OCT)-guided percutaneous coronary intervention (PCI) improves clinical outcomes through enhanced stent optimisation; however, whether these benefits extend to patients with multivessel disease (MVD), characterised by greater anatomical complexity and high ischaemic burden, remains unclear. Therefore, this study aimed to evaluate whether OCT guidance improves clinical outcomes in patients with MVD undergoing PCI.
We conducted a post hoc subgroup analysis of the OCCUPI trial, focusing on patients with MVD (diameter stenosis ≥50% in ≥2 major epicardial coronary arteries) with at least one complex lesion. The primary outcome was major adverse cardiac event (MACE), a composite of cardiac death, myocardial infarction, stent thrombosis or ischaemia-driven target-vessel revascularisation over 1 year.
Among the as-treated population in the OCCUPI trial (n=1604), 985 (61.4%) patients had MVD and 575 had single-vessel disease. In patients with MVD, OCT-guided PCI (n=515) was associated with a lower risk of 1-year MACE than angiography-guided PCI (n=470) (4.7% vs 8.9%; HR 0.51, 95% CI 0.31 to 0.85; p=0.008), with consistent treatment effects observed across disease extent (p for interaction=0.202). Among the OCT-guided patients, 355 (70.2%) achieved the prespecified OCCUPI optimisation criteria, whereas 151 (29.8%) did not. Stent optimisation was associated with significantly lower MACE rates (3.1% vs 8.6%; p=0.011) and consistent benefits were observed across MVD and single-vessel disease (p for interaction=0.521).
In patients with MVD and complex lesions, OCT-guided PCI was associated with a lower risk of 1-year MACE than angiography-guided PCI particularly when stent optimisation on OCT was achieved.

PMID:
42648894
Bibliographic data and abstract were imported from PubMed on 27 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 17
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement